F Sodini
University of Pisa
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F Sodini.
Pediatric Research | 2003
Giampiero I. Baroncelli; Giovanni Federico; Silvano Bertelloni; F Sodini; Francesca de Terlizzi; Ruggero Cadossi; Giuseppe Saggese
Bone quality by quantitative ultrasound and fracture rate were assessed in 135 (64 males) children and adolescents aged 3-21 y with bone and mineral disorders such as chronic anticonvulsants or glucocorticoids treatment, juvenile rheumatoid arthritis, celiac disease, paucity of intrahepatic bile ducts, autoimmune hepatitis, genetic diseases, idiopathic juvenile osteoporosis, disuse osteoporosis, β-thalassemia major, survivors of acute lymphoblastic leukemia, liver transplantation, calcium deficiency, and nutritional or X-linked hypophosphatemic rickets. Amplitude-dependent speed of sound through the distal end of the first phalangeal diaphysis of the last four fingers of the hand was measured by an ultrasound device. In the majority of patients cortical area to total area ratio by metacarpal radiogrammetry (n=120) and lumbar bone mineral density (BMD) by dual-energy x-ray absorptiometry (n=99) were also assessed. In patients with X-linked hypophosphatemic rickets radial BMD by single-photon absorptiometry instead of lumbar BMD was measured. Mean values of amplitude-dependent speed of sound, cortical area to total area ratio, lumbar BMDarea, or lumbar BMD corrected for bone sizes estimated by a mathematical model (BMDvolume), as well as mean values of radial BMD in patients with X-linked hypophosphatemic rickets, expressed as z score, were significantly reduced (p < 0.0001) in comparison with their reference values (−1.7 ± 1.0, −2.0 ± 0.9, −3.0 ± 1.3, −1.9 ± 1.0, −2.7 ± 0.7, respectively). A positive relationship was found between amplitudedependent speed of sound and cortical area to total area ratio (r = 0.90, p < 0.0001), lumbar BMDarea (r = 0.62, p < 0.0001), or lumbar BMDvolume (r = 0.66, p < 0.0001). Fifty-two patients (38.5%) had suffered fractures in the 6 mo preceding the bone measurements, the radial distal metaphysis being the most frequent fracture site (28.8%). Mean values of amplitude-dependent speed of sound, cortical area to total area ratio, lumbar BMDarea, or lumbar BMDvolume, expressed as z score, of fractured patients were significantly lower (p < 0.0001) than those of fracture-free patients (−2.2 ± 1.0 and −1.4 ± 0.8, −2.6 ± 0.9 and −1.7 ± 0.7, −3.5 ± 1.2 and −2.5 ± 1.0, −2.5 ± 1.0 and −1.3 ± 0.7, respectively). Phalangeal quantitative ultrasound may be a useful method to assess bone quality and fracture risk in children and adolescents with bone and mineral disorders.
Pediatric Drugs | 2005
Giampiero I. Baroncelli; Silvano Bertelloni; F Sodini; Giuseppe Saggese
Bone mass increases progressively during childhood, but mainly during adolescence when approximately 40% of total bone mass is accumulated. Peak bone mass is reached in late adolescence, and is a well recognised risk factor for osteoporosis later in life. Thus, increasing peak bone mass can prevent osteoporosis.The critical interpretation of bone mass measurements is a crucial factor for the diagnosis of osteopenia/osteoporosis in children and adolescents. To date, there are insufficient data to formally define osteopenia/osteoporosis in this patient group, and the guidelines used for adult patients are not applicable. In males and females aged <20 years the terminology ‘low bone density for chronologic age’ may be used if the Z-score is less than −2. For children and adolescents, this terminology is more appropriate than osteopenia/osteoporosis. Moreover, the T-score should not be used in children and adolescents.Many disorders, by various mechanisms, may affect the acquisition of bone mass during childhood and adolescence. Indeed, the number of disorders that have been identified as affecting bone mass in this age group is increasing as a consequence of the wide use of bone mass measurements. The increased survival of children and adolescents with chronic diseases or malignancies, as well as the use of some treatment regimens has resulted in an increase in the incidence of reduced bone mass in this age group.Experience in treating the various disorders associated with osteoporosis in childhood is limited at present. The first approach to osteoporosis management in children and adolescents should be aimed at treating the underlying disease. The use of bisphosphonates in children and adolescents with osteoporosis is increasing and their positive effect in improving bone mineral density is encouraging. Osteoporosis prevention is a key factor and it should begin in childhood. Pediatricians should have a fundamental role in the prevention of osteoporosis, suggesting strategies to achieve an optimal peak bone mass.
Clinical Endocrinology | 2004
Giampiero I. Baroncelli; Silvano Bertelloni; F Sodini; Giuseppe Saggese
objective GH treatment has an important role in the acquisition of bone mass in children and adolescents with GH deficiency (GHD). However, there is no information concerning the timing and value of peak bone mass in treated patients with GHD. In adolescents with GHD we longitudinally measured lumbar bone mineral density (BMD) after discontinuation of GH treatment at final height until they achieved lumbar peak BMD (pBMD). Moreover, the changes of lumbar BMD after the attainment of the peak were assessed for a period of 2 years. The results of patients were compared with those obtained in age‐ and sex‐matched healthy controls.
The Journal of Clinical Endocrinology and Metabolism | 2002
Giampiero I. Baroncelli; Silvano Bertelloni; F Sodini; Giuseppe Saggese
Journal of Pediatric Endocrinology and Metabolism | 2003
Giampiero I. Baroncelli; Silvano Bertelloni; F Sodini; Giuseppe Saggese
The Journal of Clinical Endocrinology and Metabolism | 2003
Giampiero I. Baroncelli; Silvano Bertelloni; Laura Galli; F Sodini; Giuseppe Saggese
Pediatric endocrinology reviews | 2004
Gi Baroncelli; Silvano Bertelloni; F Sodini; Laura Galli; T Vanacore; Lisa Fiore; Giuseppe Saggese
MINERVA Pediatrica | 2005
Paolo Ghirri; Gi Baroncelli; A Cuttano; M Vuerich; C Riparbelli; F Sodini; M Gentile; A Bartoli; Giuseppe Saggese; Antonio Boldrini
MINERVA Pediatrica | 2005
Paolo Ghirri; A Cuttaneo; M Vuerich; C Riparbelli; F Sodini; Marzia Gentile; A Bartoli; Giuseppe Saggese; Antonio Boldrini
Bone | 2005
Gi Baroncelli; Silvano Bertelloni; F Sodini; Laura Galli; T Vanacore; Giuseppe Saggese